En Es
Categories

Industry News


Nova Biomedical Adds Sample Retain Collector to BioProfile FLEX2 Cell Culture Analyzer

By Labmedica International staff writers
25 Jan 2021

Image: BioProfile FLEX2 Cell Culture Analyzer (Photo courtesy of Nova Biomedical)Nova Biomedical (Waltham, MA, USA) has added a Sample Retain Collector (SRC) for its BioProfile FLEX2 automated cell culture analyzer which measures up to 16 tests including pH, gases, metabolites, osmolality, cell density, and cell viability.

A single FLEX2 analyzer with SRC and the previously introduced Online Sampler (OLS) module provides automated sampling and analysis of these key cell culture tests from as many as 10 bioreactors. This FLEX2 automation package saves hours of time versus manual sampling, analysis, sample storage, and after-hours cell culture monitoring. The SRC automatically collects cell culture samples from the FLEX2 Online Sampler and stores them in a refrigerated environment to fulfill regulatory requirements for long-term sample retains, as well as enabling further offline testing. The SRC allows user-selectable retained sample volumes from 200uL to 50 mL at a storage temperature of 4?C. In combination with the FLEX2 and OLS, samples from up to 10 bioreactors can be analyzed and stored by the SRC in as fast as one hour.

"We have partnered with the industry leader in liquid handling systems, Teledyne Cetac, to market this system, configured specifically to work with the FLEX2," said Matt McRae, Nova Biotechnology Product Line Manager. "The Sample Retain Collection System completes the full automation package for the FLEX2, offering the truly automated sampling, analysis, sample storage and feedback control of all measured parameters that our customers need. It also enables safe storage of retains and/or later analysis of other key cell culture attributes that today's laboratories require."





E-mail Print
FaceBook Twitter Google+ Linked in

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers. Nova’s biosensor technology is incorporated into products ranging from handheld meters for self- and point-of-care testing to critical care whole blood analyzers designed for rapid measurement of over 20 analytes.
Gold member
More info

More articles about Nova Biomedical

19 Nov 2020
Nova Biomedical Launches New Laboratory Blood Glucose Reference Analyzer
Nova Biomedical (Waltham, MA, USA) has launched Nova Primary, a rapid, accurate, easy to use, blood glucose laboratory analyzer that fills the need for a new glucose reference analyzer to replace the YSI STAT PLUS 2300 Glucose and L-Lactate analyzer from YSI, Inc., (Yellow Springs, OH, USA).
Read More
20 Apr 2020
Nova's Stat EMS Basic Blood Testing System Launched in CE Mark Countries
Nova Biomedical (Waltham, MA, USA) has launched the Stat EMS Basic blood testing system for ambulance and emergency care in CE mark countries. Stat EMS Basic measures fingerstick capillary lactate, glucose, ketone, hemoglobin, and hematocrit in six to 40 seconds with laboratory-quality results.
Read More
20 Apr 2020
Nova's Stat Profile Prime Plus Blood Gas Analyzer Receives FDA Clearance for POC Use
Nova Biomedical (Waltham, MA, USA) has secured clearance from the US Food and Drug Administration (FDA) for its Stat Profile Prime Plus critical care blood gas analyzer for point-of-care (POC) use.
Read More
08 Apr 2020
Nova Biomedical Adds PT/INR Test to Allegro Analyzer for POC Testing
Nova Biomedical (Waltham, MA, USA) has added PT/INR testing for its Allegro capillary blood analyzer for point-of-care (POC) testing in primary care settings. With the ability to test for clotting disorders and monitor the effectiveness of blood-thinning medications, the Allegro and its StatStrip-A companion meter provide 18 clinically important tests to help physicians make therapeutic decisions and adjustments at the POC.
Read More
03 Jan 2020
Nova Biomedical Launches New BioProfile FLEX2 On-Line Autosampler
 Nova Biomedical (Waltham, MA, USA) has launched the BioProfile FLEX2 On-Line Autosampler (OLS), a modular system that connects as many as 10 bioreactors to one FLEX2 analyzer for up to three weeks of walkaway, automated sampling, analysis, and feedback control of key cell culture analytes. The FLEX2 measures up to 16 tests, including pH, gases, metabolites, osmolality, cell density, and cell viability.
Read More

Additional news

12 May 2021
Artificial Intelligence (AI) Program Accurately Predicts Lung Cancer Risk from CT Images
An artificial intelligence (AI) program accurately predicts the risk that lung nodules detected on screening CT will become cancerous, according to a study published in the journal Radiology.
Read More
05 May 2021
Beckman Coulter Becomes First Diagnostics Company to Offer Workflow Automation Specifically for Mid-Volume Laboratories
Beckman Coulter (Brea, CA, USA) has announced the global launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that run fewer than 5,000 tests a day.
Read More
30 Apr 2021
Siemens Reportedly Considering Sale of Its Ultrasound Business
Siemens Healthineers (Erlangen, Germany) is considering selling off its ultrasound business and has also received expressions of interest in the business.
Read More
27 Apr 2021
Researchers Use AI to Detect Wrist Fractures
An automated system that uses artificial intelligence (AI) is effective at detecting a common type of wrist fracture on X-rays, according to a study.
Read More
27 Apr 2021
Fujifilm Europe Launches New `Harmony` Version of its Amulet Innovality Mammography System
FUJIFILM Europe GmbH (Düsseldorf, Germany) has launched the new “Harmony” version of its AMULET Innovality mammography system that brings together improved diagnostic performance with new design themes to embellish and illuminate the mammography suite, creating an environment to put patients at ease.
Read More
21 Apr 2021
FDA Clears First-Ever AI Mammography Triage Software that Supports both 3D and 2D Mammography
The US Food and Drug Administration has cleared the first-ever artificial intelligence (AI) mammography triage software that supports both 3D and 2D mammography.
Read More
20 Apr 2021
Global Digital PCR and Real-Time PCR Market Growth Driven by Increasing Cases of Infectious Diseases
Increasing cases of infectious diseases, rising geriatric population and growing number of genetic disorders will propel the growth of the global digital PCR and real-time PCR market over the next decade. Additionally, PCR advances, fulfillment of the human genome project, and expanding R&D will increase the utilization of biomarker profiling for sickness diagnostics, thus further driving market growth.
Read More
19 Apr 2021
Siemens Completes Acquisition of Varian to Create Integrated Portfolio of Imaging, Laboratory Diagnostics, AI and Cancer Treatment
Siemens Healthineers (Erlangen, Germany) has successfully completed the acquisition of Varian Medical Systems, Inc. (Palo Alto, CA, USA), thus strengthening its position as a holistic partner in healthcare.
Read More
16 Apr 2021
Eppendorf Introduces Multipurpose Centrifuge 5910 Ri to Accelerate Results
Eppendorf AG (Hamburg, Germany) has introduced a new centrifuge designed to increase efficiency in the laboratory, Centrifuge 5910 Ri, a successor to the company’s popular Centrifuge 5910 R.
Read More
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions